A. Molisak

Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils

L. Lannfelt, M. Ingelsson, C. Möller, 2023, Aging brain.

CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation

Martin J. Aryee, J. Joung, V. Pattanayak, 2022, Molecular therapy. Nucleic acids.